The Paragon 28® Research and Grant Committee will review and consider all completed research proposals that are relevant to foot & ankle.
Some areas of interest are:
• Clinical outcomes and patient reported outcomes related to Paragon 28® products
• Health economics and outcomes research
• Research comparing healthy, diseased, and treated states
• Biomechanical evaluations including cadaveric, in vivo, and computational studies
Incomplete applications will not be considered.
Paragon 28® follows the AdvaMed Code of Ethics on Interactions with U.S. Health Care Professionals, as well as other similar international codes. The provision of a research grant shall not be related, directly or indirectly, to the volume or value of purchases or referrals made by or anticipated from the recipient nor shall the grant be used as an unlawful inducement. No direct payments will be made payable to individuals or healthcare professionals.
The U.S. Physician Payments Sunshine Act requires all pharmaceutical, biologic, and medical device manufacturers to report annually to the U.S. government payments and transfers of value made to certain U.S. healthcare professionals and teaching hospitals. This includes funding for research and grants. Certain international countries may require similar reporting pursuant to relevant disclosure and transparency laws.